CHINADA 2016 Annual Report / China Anti-Doping Agency (CHINADA). - Beijing : CHINADA, 2017
Used filter(s): 155 items found
- Remove all filters
- Search all: meldonium
CHINADA Annual Report 2016 (China)
CCES Annual Report 2016-2017 (Canada)
Annual report 2016-2017 / Canadian Centre for Ethics in Sport (CCES). - Ottawa : CCES, 2017
Contents:
- Our Message to You
- Governance and Leadership
- Activate
- Advocate
- Protect
- Doping Control Statistics
- Financial Report
ADC Annual Report 2021 (Bulgaria)
2021 Annual Statistical Report On Doping Control / Bulgarian Anti-Doping Centre (ADC). - Sofia : ADC, 2022
ADC Annual Report 2019 (Bulgaria)
2019 Annual Statistical Report On Doping Control / Bulgarian Anti-Doping Centre (ADC). - Sofia : ADC, 2020
ADC Annual Report 2018 (Bulgaria)
2018 Annual Statistical Report On Doping Control / Bulgarian Anti-Doping Centre (ADC). - Sofia : ADC, 2019
Dopingautoriteit Annual Report 2019 (Netherlands)
Dopingautoriteit Annual Report 2019 (Netherlands) / Anti-doping Authority Netherlands (Dopingautoriteit). - Capelle aan den IJssel : Dopingautoriteit, 2020
Contents:
Chapter 1 – Education
Chapter 2 – Doping Control
Chapter 3 – Intelligence & Investigations
Chapter 4 – Disciplinary Proceedings
Chapter 5 – Legal Affairs
Chapter 6 – Scientific Research
Chapter 7 – Knowledge Management
Chapter 8 – Therapeutic Use Exemptions
Chapter 9 – International Affairs
Chapter 10 – People & Organisation
--------------------------
Annex 1 - Financial overview
Annex 2 - Members of the Advisory Board and Committees
Annex 3 - Office staff
Annex 4 - Overview of publications and presentations
Annex 5 - Secondary positions
Annex 6 - Abbreviations
Dopingautoriteit Annual Report 2018 (Netherlands)
Dopingautoriteit Annual Report 2018 (Netherlands) / Anti-doping Authority Netherlands (Dopingautoriteit). - Capelle aan den IJssel : Dopingautoriteit, 2019
Contents:
Chapter 1 – Prevention
Chapter 2 – Therapeutic Use Exemptions
Chapter 3 – Doping control
Chapter 4 – Intelligence & Investigations
Chapter 5 – Disciplinary Proceedings
Chapter 6 – International Affairs
Chapter 7 – Legal Affairs
Chapter 8 – Scientific research
Chapter 9 – Knowledge management
Chapter 10 – People & organisation
--------------------------
Annex 1 - Financial overview
Annex 2 - Members of the Board of Management, Advisory Board and Committees
Annex 3 - Office staff
Annex 4 - Overview of doping control officials
Annex 5 - Overview of publications and presentations
Annex 6 - Secondary positions
Annex 7 - Abbreviations
ITF 2021 ITF vs Elizaveta Demina
In January 2022 the International Tennis Federation (ITF) has reported an anti-doping rule violation against the Russian tennis player Elizavetka Demina after her A and B samples tested positive for the prohibited substance Meldonium.
After notification the Athlete gave a prompt admission, waived her right for a hearing, accepted the provisional suspension and the decision rendered by the ITF. The Athlete admitted that prior in August 2021 she had used Mildronate over two week in order to recover after a period of intense training.
The ITF finds that the presence of a prohibited substance has been established in the Athlete's samples and accordingly that she committed an anti-doping rule violation. The ITF deems that the Athlete had not attempted to demonstrate that the violation was not intentional and considers that she gave an early admission and acceptance of sanction.
Therefore the ITF decides on 30 March 2022 to impose a 3 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 21 January 2022.